Glucotrack (GCTK) EPS (Weighted Average and Diluted) (2016 - 2020)
Historic EPS (Weighted Average and Diluted) for Glucotrack (GCTK) over the last 7 years, with Q4 2020 value amounting to $0.31.
- Glucotrack's EPS (Weighted Average and Diluted) rose 320000.0% to $0.31 in Q4 2020 from the same period last year, while for Dec 2020 it was $0.23, marking a year-over-year increase of 10603.67%. This contributed to the annual value of $0.38 for FY2023, which is N/A changed from last year.
- Latest data reveals that Glucotrack reported EPS (Weighted Average and Diluted) of $0.31 as of Q4 2020, which was up 320000.0% from -$0.03 recorded in Q3 2020.
- In the past 5 years, Glucotrack's EPS (Weighted Average and Diluted) registered a high of $0.31 during Q4 2020, and its lowest value of -$3.78 during Q4 2018.
- Over the past 5 years, Glucotrack's median EPS (Weighted Average and Diluted) value was -$0.28 (recorded in 2016), while the average stood at -$0.43.
- As far as peak fluctuations go, Glucotrack's EPS (Weighted Average and Diluted) plummeted by 70425.53% in 2018, and later skyrocketed by 320000.0% in 2020.
- Over the past 5 years, Glucotrack's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.23 in 2016, then tumbled by 105.86% to -$0.47 in 2017, then tumbled by 704.26% to -$3.78 in 2018, then skyrocketed by 99.74% to -$0.01 in 2019, then soared by 3200.0% to $0.31 in 2020.
- Its EPS (Weighted Average and Diluted) stands at $0.31 for Q4 2020, versus -$0.03 for Q3 2020 and -$0.04 for Q2 2020.